Hitting bacteria hard and early with diverse phage cocktails may curb resistance

As multidrug antibiotic resistance becomes an urgent public health concern, scientists are turning to bacteriophage therapy. Bacteriophages, or phages, are viruses that seek out and infect bacteria, ultimately destroying them. Researchers have now modeled the dynamics of bacteriophage therapy to optimize the composition of bacteriophage cocktails and improve treatment outcomes.

Alan Perelson, a scientist at Los Alamos National Laboratory and co-author of the research, explained that phages are prevalent everywhere bacteria exist, but each phage specifically targets certain bacteria, and bacteria have developed resistance mechanisms. Phage cocktails, or combinations of phages tailored for a specific bacterial infection, represent personalized medicine.

However, the complex dynamics of bacterial responses to phages make it difficult to predict whether a particular therapy will succeed or fail. The researchers developed a mathematical model based on data from phage therapy in live mice, then extended it to humans to include multiple phages targeting multiple bacterial strains with varying resistance levels.

The model identified key factors that influence phage therapy success, such as the bacteria's pretreatment resistance level, the diversity of the phage cocktail, and the timing of its delivery. A diverse phage cocktail overwhelms the bacteria's ability to evolve resistance quickly, creating a high genetic barrier that makes it difficult for bacteria to survive the therapy.

Immediate administration of the full phage cocktail resulted in the best outcomes, as it prevents resistant bacteria from expanding and mutating to avoid infection. In essence, the key to effective phage therapy is to "hit the bacteria hard and early."